Furthermore, the treatment of secondary progressive MS with cyclophosphamide, which has both immunosuppressive and immunomodulatory effects, increased the percentages of CCR4-expressing T cells that produce IL-4 and reversed detrimental IFN-γ production in CD8+ T cells [87]. Here, IL4 is linked to myeloid sarcoma.